Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Castera

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal De Radiologie, D'Electrologie, Et De Medecine Nucleaire|November 1, 1978
[Hyperfractionated radiotherapy in 56 patients with tumors of the head and neck (author's transl)]D Castera, M Legros, J Mouillet
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|March 1, 1978
[Hyperfractionated irradiation with cobalt 60 in ORL cancers]M Legros, D Castera, A Longuebray, et al.
Anticancer Research|January 30, 2003
Efficacy of prophylactic anti-diarrhoeal treatment in patients receiving Campto for advanced colorectal cancerJ Duffour, S Gourgou, J F Seitz, et al.
British Journal of Cancer|October 10, 2007
Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO groupI Ray-Coquard, D Paraiso, J-P Guastalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patientsJ L Misset, P Vennin, P H Chollet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†B Chauffert, L Feuvret, F Bonnetain, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal De Radiologie, D'Electrologie, Et De Medecine Nucleaire|November 1, 1978
[Hyperfractionated radiotherapy in 56 patients with tumors of the head and neck (author's transl)]D Castera, M Legros, J Mouillet
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|March 1, 1978
[Hyperfractionated irradiation with cobalt 60 in ORL cancers]M Legros, D Castera, A Longuebray, et al.
Anticancer Research|January 30, 2003
Efficacy of prophylactic anti-diarrhoeal treatment in patients receiving Campto for advanced colorectal cancerJ Duffour, S Gourgou, J F Seitz, et al.
British Journal of Cancer|October 10, 2007
Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO groupI Ray-Coquard, D Paraiso, J-P Guastalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patientsJ L Misset, P Vennin, P H Chollet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†B Chauffert, L Feuvret, F Bonnetain, et al.
Pageof 1